What will the prevailing sentiment be about Rapamycin as a longevity drug in 2028?
Premium
6
Ṁ2772028
11%
Wonder-drug: Most adults should consider it
22%
Valuable but imperfect: Some healthy adults should consider it, but there are major drawbacks
25%
Unproven but promising: Too early to tell
30%
Ineffective: Any benefits are too small to be worth the drawbacks
12%
Harmful/scandalous: Clear serious drawbacks that last beyond cessation of treatment
I'll post a proposed resolution here for discussion at least one week before resolving. May resolve to a mixture of up to two different choices in borderline cases.
If there's any substantial disagreement, I'll ask a popular LLM-style chatbot to select a resolution based on the title of the market, the choices, and the text of the ten first Google News results for "rapamycin for longevity".
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Related questions
Related questions
Will a senolytic drug be used clinically to slow, prevent, or reverse aging by the end of 2033?
61% chance
What percent of those taking rapamycin to slow aging will comment a positive or neutral review?
56% chance
Will Stephen Wolfram self-report or get in the news 4 any pro-longevity intervention (eg rapamycin/ozempic) by EOY 2028?
32% chance
Will Peter Thiel start regularly taking rapamycin by EOY 2027?
35% chance
Will any molecule be shown to extend longevity in the ITP program in 2024?
48% chance
Will jurgen schmidhuber end up taking rapamycin by EOY 2028
41% chance
Will a study performed by the Dog Aging Project show a statistically significant effect of rapamycin on lifespan extension between control groups and a treatment group?
73% chance
By 2030, will any treatment be shown to increase human lifespan in a randomized controlled trial?
Will anti-aging treatments developed, approved and available for public usage by 2040?
46% chance
Will Jose Luis ricon finally start regularly taking rapamycin by 2030?
45% chance